GSK Expands Treasury Stock With Latest £7m Share Buyback Tranche

robot
Abstract generation in progress

GSK has continued its share buyback program, repurchasing 330,000 ordinary shares on April 17, 2026, for £7 million, adding them to treasury. This latest transaction brings total repurchases since February 2026 to nearly 19.9 million shares, reinforcing GSK’s capital-return strategy and updating shareholder voting-rights calculations. Spark, TipRanks’ AI Analyst, rates GSK as Neutral due to strong profitability, constructive 2026 guidance, and reasonable valuation, despite technical overbought risk.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin